Orange Book product · Generic (ANDA)
IOPAMIDOL
IOPAMIDOL
At a glance
Sep 27, 2023
Approved
Generic (ANDA)
Application
AP2
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 27, 2023
2 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
IOPAMIDOL
Strength
41%
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP2
Application
ANDA 217134
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IOPAMIDOL
- 1994ISOVUE-200Brand (NDA)
NDA 020327 · BRACCO
- 1986ISOVUE-128Brand (NDA)
NDA 018735 · BRACCO
- 2023IOPAMIDOLGeneric (ANDA)
ANDA 215382 · HAINAN POLY
- 2010SCANLUX-300Generic (ANDA)
ANDA 090394 · SANOCHEMIA CORP USA
- 2000IOPAMIDOL-200Generic (ANDA)
ANDA 074881 · COOK IMAGING
- 1998IOPAMIDOL-250Generic (ANDA)
ANDA 075005 · HOSPIRA
- 1997IOPAMIDOL-200Generic (ANDA)
ANDA 074898 · HOSPIRA
- 1997IOPAMIDOL-200 IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 074636 · HOSPIRA
- 1997IOPAMIDOL-300Generic (ANDA)
ANDA 074638 · ABBVIE
- 1997IOPAMIDOL-300 IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 074637 · HOSPIRA
- 1997IOPAMIDOL-250Generic (ANDA)
ANDA 074679 · FRESENIUS KABI USA
- 1996IOPAMIDOLGeneric (ANDA)
ANDA 074734 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
